Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema. A randomized, double-blind study.

作者: DEMOSTHENES BOUROS , SOPHIA SCHIZA , NIKOLAOS TZANAKIS , GEORGE CHALKIADAKIS , JOHN DROSITIS

DOI: 10.1164/AJRCCM.159.1.9803094

关键词: Chest tubeUrokinaseMedicineFibrinolytic agentSurgeryPleural diseaseRespiratory diseaseThoracoscopyPleurisyEmpyema

摘要: Intrapleural administration of fibrinolytic agents has been shown to be effective and safe in the treatment loculated parapneumonic pleural effusions. However, controlled studies possible role activity urokinase (UK) through volume effect are lacking. We therefore investigated hypothesis that UK is lysis adhesions not effect. Thirty-one consecutive patients with multiloculated effusions were randomly assigned receive either intrapleural (15 patients) or normal saline (NS) (16 for 3 d, a double-blind manner. All had inadequate drainage chest tube (< 70 ml/24 h). was given daily dose 100.000 IU diluted 100 ml NS. Controls same NS intrapleurally. Response assessed by clinical outcome, fluid drainage, radiography, ultrasonography (US) and/or computed tomography (CT). Clinical radiographic improvement noted all but two group only four control group. The net mean drained during 3-d period significantly greater (970 +/- 75 versus 280 55 ml, p < 0.001). Pleural complete 13 (86.5%) (two treated video-assisted thoracoscopy) (25%) Twelve subsequently six them drainage; remaining after thoracoscopy. Our results suggest

参考文章(32)
S Larsson, P Nagy, R Ekroth, N P Bergh, Intrapleural streptokinase in the treatment of haemothorax and empyema. Scandinavian Cardiovascular Journal. ,vol. 11, pp. 265- 268 ,(1977)
Sandra K. Willsie-Ediger, Gary Salzman, George Reisz, Marilyn G. Foreman, Use of Intrapleural Streptokinase in the Treatment of Thoracic Empyema The American Journal of the Medical Sciences. ,vol. 300, pp. 296- 300 ,(1990) , 10.1097/00000441-199011000-00005
Charlie Strange, Mary Lynn Allen, Russell Harley, John Lazarchick, Steven A. Sahn, Intrapleural streptokinase in experimental empyema. The American review of respiratory disease. ,vol. 147, pp. 962- 966 ,(1993) , 10.1164/AJRCCM/147.4.962
D Bouros, S Schiza, G Patsourakis, G Chalkiadakis, P Panagou, N M Siafakas, Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions: a prospective, double-blind study. American Journal of Respiratory and Critical Care Medicine. ,vol. 155, pp. 291- 295 ,(1997) , 10.1164/AJRCCM.155.1.9001327
Michael A. Wait, Sashi Sharma, Joyce Hohn, Anthony Dal Nogare, A Randomized Trial of Empyema Therapy Chest. ,vol. 111, pp. 1548- 1551 ,(1997) , 10.1378/CHEST.111.6.1548
R F Taylor, M B Rubens, M C Pearson, N C Barnes, Intrapleural streptokinase in the management of empyema. Thorax. ,vol. 49, pp. 856- 859 ,(1994) , 10.1136/THX.49.9.856
Jeffrey S. Pollak, Cary S. Passik, Intrapleural Urokinase in the Treatment of Loculated Pleural Effusions Chest. ,vol. 105, pp. 868- 873 ,(1994) , 10.1378/CHEST.105.3.868
Charlie Strange, Steven A. Sahn, The Clinician's Perspective on Parapneumonic Effusions and Empyema Chest. ,vol. 103, pp. 259- 261 ,(1993) , 10.1378/CHEST.103.1.259
Craig A. Henke, James W. Leatherman, Intrapleurally administered streptokinase in the treatment of acute loculated nonpurulent parapneumonic effusions. The American review of respiratory disease. ,vol. 145, pp. 680- 684 ,(1992) , 10.1164/AJRCCM/145.3.680